2020-06-24
Positive results from Phase 2 study
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.
Read more: https://www.camurus.com
2020-06-24
Positive results from Phase 2 study of once-weekly FluidCrystal® formulation of setmelanotide in healthy volunteers with obesity.
Read more: https://www.camurus.com
2020-12-14
Camurus announced on December 10, 2020, that the ICC International Court of Arbitration has issued a partial award i…
Read more2020-12-02
Camurus AB today announced that Camurus licensee Braeburn has received a Complete Response Letter (CRL) from the US…
Read more2020-12-02
GAIM launches their new website on the domain www.gaim.com
Read more2020-11-06
"Good performances were seen across markets and we are on track to deliver on our revenue guidance."
Read more2020-07-29
ISEC Monitoring Systems has received three substantial and strategically important orders during the last year, amou…
Read more